Report Detail
Global Oral Antiviral Medicines for COVID-19 Market Growth 2022-2028
- RnM4483955 |
- 16 August, 2022 |
- Global |
- 90 Pages |
- LPI(LP Information) |
- Technology
The global market for Oral Antiviral Medicines for COVID-19 is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Oral Antiviral Medicines for COVID-19 market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Oral Antiviral Medicines for COVID-19 market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Oral Antiviral Medicines for COVID-19 market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Oral Antiviral Medicines for COVID-19 market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Oral Antiviral Medicines for COVID-19 players cover Pfizer, Merck, Shionogi, Simcere Pharmaceutical and Frontier Biotechnologies and etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Oral Antiviral Medicines for COVID-19 market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Oral Antiviral Medicines for COVID-19 market, with both quantitative and qualitative data, to help readers understand how the Oral Antiviral Medicines for COVID-19 market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in Units.
Market Segmentation:
The study segments the Oral Antiviral Medicines for COVID-19 market and forecasts the market size by Type (Lagevrio, Paxlovid and Azvudine), by Application (Aldult and Elder.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Lagevrio
Paxlovid
Azvudine
Segmentation by application
Aldult
Elder
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Pfizer
Merck
Shionogi
Simcere Pharmaceutical
Frontier Biotechnologies
Kexing Biopharm
Chapter Introduction
Chapter 1: Scope of Oral Antiviral Medicines for COVID-19, Research Methodology, etc.
Chapter 2: Executive Summary, global Oral Antiviral Medicines for COVID-19 market size (sales and revenue) and CAGR, Oral Antiviral Medicines for COVID-19 market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Oral Antiviral Medicines for COVID-19 sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Oral Antiviral Medicines for COVID-19 sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Oral Antiviral Medicines for COVID-19 market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Pfizer, Merck, Shionogi, Simcere Pharmaceutical, Frontier Biotechnologies and Kexing Biopharm, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Oral Antiviral Medicines for COVID-19 Annual Sales 2017-2028
- 2.1.2 World Current & Future Analysis for Oral Antiviral Medicines for COVID-19 by Geographic Region, 2017, 2022 & 2028
- 2.1.3 World Current & Future Analysis for Oral Antiviral Medicines for COVID-19 by Country/Region, 2017, 2022 & 2028
- 2.2 Oral Antiviral Medicines for COVID-19 Segment by Type
- 2.2.1 Lagevrio
- 2.2.2 Paxlovid
- 2.2.3 Azvudine
- 2.3 Oral Antiviral Medicines for COVID-19 Sales by Type
- 2.3.1 Global Oral Antiviral Medicines for COVID-19 Sales Market Share by Type (2017-2022)
- 2.3.2 Global Oral Antiviral Medicines for COVID-19 Revenue and Market Share by Type (2017-2022)
- 2.3.3 Global Oral Antiviral Medicines for COVID-19 Sale Price by Type (2017-2022)
- 2.4 Oral Antiviral Medicines for COVID-19 Segment by Application
- 2.4.1 Aldult
- 2.4.2 Elder
- 2.5 Oral Antiviral Medicines for COVID-19 Sales by Application
- 2.5.1 Global Oral Antiviral Medicines for COVID-19 Sale Market Share by Application (2017-2022)
- 2.5.2 Global Oral Antiviral Medicines for COVID-19 Revenue and Market Share by Application (2017-2022)
- 2.5.3 Global Oral Antiviral Medicines for COVID-19 Sale Price by Application (2017-2022)
3 Global Oral Antiviral Medicines for COVID-19 by Company
- 3.1 Global Oral Antiviral Medicines for COVID-19 Breakdown Data by Company
- 3.1.1 Global Oral Antiviral Medicines for COVID-19 Annual Sales by Company (2020-2022)
- 3.1.2 Global Oral Antiviral Medicines for COVID-19 Sales Market Share by Company (2020-2022)
- 3.2 Global Oral Antiviral Medicines for COVID-19 Annual Revenue by Company (2020-2022)
- 3.2.1 Global Oral Antiviral Medicines for COVID-19 Revenue by Company (2020-2022)
- 3.2.2 Global Oral Antiviral Medicines for COVID-19 Revenue Market Share by Company (2020-2022)
- 3.3 Global Oral Antiviral Medicines for COVID-19 Sale Price by Company
- 3.4 Key Manufacturers Oral Antiviral Medicines for COVID-19 Producing Area Distribution, Sales Area, Product Type
- 3.4.1 Key Manufacturers Oral Antiviral Medicines for COVID-19 Product Location Distribution
- 3.4.2 Players Oral Antiviral Medicines for COVID-19 Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Oral Antiviral Medicines for COVID-19 by Geographic Region
- 4.1 World Historic Oral Antiviral Medicines for COVID-19 Market Size by Geographic Region (2017-2022)
- 4.1.1 Global Oral Antiviral Medicines for COVID-19 Annual Sales by Geographic Region (2017-2022)
- 4.1.2 Global Oral Antiviral Medicines for COVID-19 Annual Revenue by Geographic Region
- 4.2 World Historic Oral Antiviral Medicines for COVID-19 Market Size by Country/Region (2017-2022)
- 4.2.1 Global Oral Antiviral Medicines for COVID-19 Annual Sales by Country/Region (2017-2022)
- 4.2.2 Global Oral Antiviral Medicines for COVID-19 Annual Revenue by Country/Region
- 4.3 Americas Oral Antiviral Medicines for COVID-19 Sales Growth
- 4.4 APAC Oral Antiviral Medicines for COVID-19 Sales Growth
- 4.5 Europe Oral Antiviral Medicines for COVID-19 Sales Growth
- 4.6 Middle East & Africa Oral Antiviral Medicines for COVID-19 Sales Growth
5 Americas
- 5.1 Americas Oral Antiviral Medicines for COVID-19 Sales by Country
- 5.1.1 Americas Oral Antiviral Medicines for COVID-19 Sales by Country (2017-2022)
- 5.1.2 Americas Oral Antiviral Medicines for COVID-19 Revenue by Country (2017-2022)
- 5.2 Americas Oral Antiviral Medicines for COVID-19 Sales by Type
- 5.3 Americas Oral Antiviral Medicines for COVID-19 Sales by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Oral Antiviral Medicines for COVID-19 Sales by Region
- 6.1.1 APAC Oral Antiviral Medicines for COVID-19 Sales by Region (2017-2022)
- 6.1.2 APAC Oral Antiviral Medicines for COVID-19 Revenue by Region (2017-2022)
- 6.2 APAC Oral Antiviral Medicines for COVID-19 Sales by Type
- 6.3 APAC Oral Antiviral Medicines for COVID-19 Sales by Application
- 6.4 China
- 6.5 Japan
- 6.6 South Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 China Taiwan
7 Europe
- 7.1 Europe Oral Antiviral Medicines for COVID-19 by Country
- 7.1.1 Europe Oral Antiviral Medicines for COVID-19 Sales by Country (2017-2022)
- 7.1.2 Europe Oral Antiviral Medicines for COVID-19 Revenue by Country (2017-2022)
- 7.2 Europe Oral Antiviral Medicines for COVID-19 Sales by Type
- 7.3 Europe Oral Antiviral Medicines for COVID-19 Sales by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Oral Antiviral Medicines for COVID-19 by Country
- 8.1.1 Middle East & Africa Oral Antiviral Medicines for COVID-19 Sales by Country (2017-2022)
- 8.1.2 Middle East & Africa Oral Antiviral Medicines for COVID-19 Revenue by Country (2017-2022)
- 8.2 Middle East & Africa Oral Antiviral Medicines for COVID-19 Sales by Type
- 8.3 Middle East & Africa Oral Antiviral Medicines for COVID-19 Sales by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
- 10.1 Raw Material and Suppliers
- 10.2 Manufacturing Cost Structure Analysis of Oral Antiviral Medicines for COVID-19
- 10.3 Manufacturing Process Analysis of Oral Antiviral Medicines for COVID-19
- 10.4 Industry Chain Structure of Oral Antiviral Medicines for COVID-19
11 Marketing, Distributors and Customer
- 11.1 Sales Channel
- 11.1.1 Direct Channels
- 11.1.2 Indirect Channels
- 11.2 Oral Antiviral Medicines for COVID-19 Distributors
- 11.3 Oral Antiviral Medicines for COVID-19 Customer
12 World Forecast Review for Oral Antiviral Medicines for COVID-19 by Geographic Region
- 12.1 Global Oral Antiviral Medicines for COVID-19 Market Size Forecast by Region
- 12.1.1 Global Oral Antiviral Medicines for COVID-19 Forecast by Region (2023-2028)
- 12.1.2 Global Oral Antiviral Medicines for COVID-19 Annual Revenue Forecast by Region (2023-2028)
- 12.2 Americas Forecast by Country
- 12.3 APAC Forecast by Region
- 12.4 Europe Forecast by Country
- 12.5 Middle East & Africa Forecast by Country
- 12.6 Global Oral Antiviral Medicines for COVID-19 Forecast by Type
- 12.7 Global Oral Antiviral Medicines for COVID-19 Forecast by Application
13 Key Players Analysis
- 13.1 Pfizer
- 13.1.1 Pfizer Company Information
- 13.1.2 Pfizer Oral Antiviral Medicines for COVID-19 Product Offered
- 13.1.3 Pfizer Oral Antiviral Medicines for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.1.4 Pfizer Main Business Overview
- 13.1.5 Pfizer Latest Developments
- 13.2 Merck
- 13.2.1 Merck Company Information
- 13.2.2 Merck Oral Antiviral Medicines for COVID-19 Product Offered
- 13.2.3 Merck Oral Antiviral Medicines for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.2.4 Merck Main Business Overview
- 13.2.5 Merck Latest Developments
- 13.3 Shionogi
- 13.3.1 Shionogi Company Information
- 13.3.2 Shionogi Oral Antiviral Medicines for COVID-19 Product Offered
- 13.3.3 Shionogi Oral Antiviral Medicines for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.3.4 Shionogi Main Business Overview
- 13.3.5 Shionogi Latest Developments
- 13.4 Simcere Pharmaceutical
- 13.4.1 Simcere Pharmaceutical Company Information
- 13.4.2 Simcere Pharmaceutical Oral Antiviral Medicines for COVID-19 Product Offered
- 13.4.3 Simcere Pharmaceutical Oral Antiviral Medicines for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.4.4 Simcere Pharmaceutical Main Business Overview
- 13.4.5 Simcere Pharmaceutical Latest Developments
- 13.5 Frontier Biotechnologies
- 13.5.1 Frontier Biotechnologies Company Information
- 13.5.2 Frontier Biotechnologies Oral Antiviral Medicines for COVID-19 Product Offered
- 13.5.3 Frontier Biotechnologies Oral Antiviral Medicines for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.5.4 Frontier Biotechnologies Main Business Overview
- 13.5.5 Frontier Biotechnologies Latest Developments
- 13.6 Kexing Biopharm
- 13.6.1 Kexing Biopharm Company Information
- 13.6.2 Kexing Biopharm Oral Antiviral Medicines for COVID-19 Product Offered
- 13.6.3 Kexing Biopharm Oral Antiviral Medicines for COVID-19 Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.6.4 Kexing Biopharm Main Business Overview
- 13.6.5 Kexing Biopharm Latest Developments
14 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Oral Antiviral Medicines for COVID-19. Industry analysis & Market Report on Oral Antiviral Medicines for COVID-19 is a syndicated market report, published as Global Oral Antiviral Medicines for COVID-19 Market Growth 2022-2028. It is complete Research Study and Industry Analysis of Oral Antiviral Medicines for COVID-19 market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
